Advanced search
Publication Cover
All Life Volume 17, 2024 - Issue 1
Submit an article Journal homepage
232
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome

Ying Chena Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information
,
Yue Wua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;c Medical School, Ningbo University, Ningbo, People’s Republic of ChinaView further author information
,
Ting Chenc Medical School, Ningbo University, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaView further author information
,
Duobing Zoua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information
,
Cong Shia Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information
,
Ningning Wua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaView further author information
,
Lixia Shengb Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaView further author information
,
Guifang Ouyangb Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of China;d Hematology Department, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Qitian Mua Laboratory of Stem Cell Transplantation, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China;b Ningbo Clinical Research Center For Hematologic Malignancies, Ningbo, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2343710 | Received 11 Dec 2023, Accepted 04 Apr 2024, Published online: 23 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.